Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21234744 | 0.86 | PRKDC (0.41) | ALDH1A1SMN1; SMN2MAPTKMT2AALDH1A3 | |
| SCHEMBL7250022 | 0.80 | CYP2A6 (0.45) | CYP2A6 | |
| SCHEMBL4570581 | 0.69 | CYP2A6 (0.39) | CYP2A6 | |
| SCHEMBL17385341 | 0.68 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2MAPTKMT2A | |
| SCHEMBL8702014 | 0.67 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2MAPTPSMD14KMT2A | |
| SCHEMBL22829572 | 0.67 | CYP2A6 (0.39) | CYP2A6 | |
| SCHEMBL32676141 | 0.66 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2MAPTPSMD14KMT2A | |
| SCHEMBL1260268 | 0.66 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2MAPTPSMD14KMT2A | |
| SCHEMBL21234924 | 0.66 | CYP2A6 (0.35) | CYP2A6 | |
| SCHEMBL13084791 | 0.64 | CYP2A6 (0.56) | ALDH1A1MAPTCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365203-B2 | Fluorescent dye and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD. (CN) | 2022-06-21 | — | — | US | disclosed |
| US-20190241584-A1 | FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241584-A1 | FLUORESCENT DYE AND PREPARATION METHOD AND USE THEREOF | DNASE1, POLRMT, DCLRE1B | ALDH1A1 422/4885SMN1; SMN2 1668/4885MAPT 2048/4885 |
| US-11365203-B2 | Fluorescent dye and preparation method and use thereof | DNASE1, POLRMT, DCLRE1B | ALDH1A1 422/4885SMN1; SMN2 1668/4885MAPT 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.